Raju S. Kucherlapati

Fondateur chez Metamark Genetics, Inc. Fortune : 4 M $ au 31/07/2026

Profil

Raju S.
Kucherlapati founded Cell Genesys, Inc. in 1988, where he worked as Director from 1988 to 1992, Millennium Pharmaceuticals, Inc. in 1993, where he worked as Director from 1993 to 2009, Abgenix, Inc. in 1993, where he worked as Director from 1993 to 2005, Metamark Genetics, Inc. in 2009, where he is working as Director from 2009, Enlight Biosciences LLC in 2008, where he worked as Director, and Kew, Inc. in 2010, where he is working as Director from 2015.
Dr. Kucherlapati also currently works at Tal Medical, Inc., as Director from 2015, Big Brothers Big Sisters of Massachusetts Bay, as Director from 2014, PureTech Management, Inc., as Director & Senior Partner, National Academy of Sciences, as Member-Institute of Medicine, National Academy of Medicine (United States), as Member, Harvard Medical School, as Professor from 2001, National Academy of Medicine, as Member from 2008, and Catalio Capital Management LP, as Venture Partner.
Dr. Kucherlapati also formerly worked at PureTech Health Plc, as Chairman from 2023 to 2025, Gelesis, Inc., as Director from 2016 to 2022, PureTech Health LLC, as Independent Non-Executive Director from 2014 to 2015, AVEO Pharmaceuticals, Inc., as Independent Director from 2011 to 2021, Harvard Partners Center for Genetics & Genomics, as Scientific Director from 2001 to 2008, resTORbio, Inc., as Director, Gelesis Holdings, Inc., as Independent Director from 2022 to 2023, Princeton University, as Assistant Professor, the University of Illinois, as Principal, Albert Einstein College of Medicine, Inc., as Principal, and New England Journal of Medicine, as Member-Editorial Board.
Dr. Kucherlapati received his graduate degree in 1972 from the University of Illinois, doctorate degree from the University of Illinois, graduate degree from Andhra University, undergraduate degree from Pithapur Rajah's Government College, and undergraduate degree in 1975 from Yale University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
PURETECH HEALTH PLC 1,06%	01/07/2025	2 568 852 ( 1,06% )	4 M $	31/07/2026

Postes actifs de Raju S. Kucherlapati

Sociétés	Poste	Début
National Academy of Medicine (United States)	Corporate Officer/Principal	21/12/2009
Metamark Genetics, Inc.	Fondateur	01/11/2009
Harvard Medical School	Corporate Officer/Principal	05/04/2011
Kew, Inc.	Fondateur	01/01/2010
Big Brothers Big Sisters of Massachusetts Bay	Directeur/Membre du Conseil	22/07/2014
Tal Medical, Inc.	Directeur/Membre du Conseil	21/04/2015
PureTech Management, Inc.	Directeur/Membre du Conseil	-
National Academy of Sciences	Corporate Officer/Principal	-
National Academy of Medicine	Corporate Officer/Principal	01/01/2008
░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░	░░░░░░░ ░░░░░░ ░░░░░░░░	-

Anciens postes connus de Raju S. Kucherlapati

Sociétés	Poste	Fin
░░░░░░░░ ░░░░░░ ░░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░